0.6967
price up icon1.97%   0.0135
after-market Handel nachbörslich: .71 0.0133 +1.91%
loading

Io Biotech Inc Aktie (IOBT) Neueste Nachrichten

pulisher
Dec 02, 2025

IO Biotech (IOBT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 01, 2025

How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews

Dec 01, 2025
pulisher
Nov 27, 2025

Will IO Biotech Inc. stock reach all time highs in 2025July 2025 Levels & Growth Focused Stock Reports - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 27, 2025

Research Recommendations For IO Biotech Inc (IOBT): Here is What You Should Know - fostersleader.com

Nov 27, 2025
pulisher
Nov 27, 2025

Analyst Downgrade: How IO Biotech Inc. stock benefits from strong dollarJuly 2025 Movers & Free Growth Oriented Trading Recommendations - moha.gov.vn

Nov 27, 2025
pulisher
Nov 26, 2025

How strong is IO Biotech Inc. stock balance sheetMarket Performance Recap & Long-Term Safe Investment Plans - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 26, 2025

Aug Wrap: What margin trends mean for IO Biotech Inc. stockJuly 2025 Decliners & Real-Time Volume Analysis Alerts - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 26, 2025

IO Biotech Announces Participation in Upcoming December Investor Conferences - The Manila Times

Nov 26, 2025
pulisher
Nov 26, 2025

IO Biotech (Nasdaq: IOBT) to Join Evercore, Piper Sandler December Investor Events - Stock Titan

Nov 26, 2025
pulisher
Nov 24, 2025

IOBTRemeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - mx.advfn.com

Nov 24, 2025
pulisher
Nov 24, 2025

It makes sense and dollars to buy IO Biotech Inc (IOBT) stock - Setenews

Nov 24, 2025
pulisher
Nov 23, 2025

IO Biotech (NASDAQ:IOBT) Stock Rating Upgraded by Wall Street Zen - Defense World

Nov 23, 2025
pulisher
Nov 23, 2025

Ligand Pharmaceuticals (NASDAQ:LGND) and IO Biotech (NASDAQ:IOBT) Financial Review - Defense World

Nov 23, 2025
pulisher
Nov 22, 2025

IO Biotech announces resignation of chief accounting officer and new appointment - Investing.com Australia

Nov 22, 2025
pulisher
Nov 21, 2025

IO Biotech Announces Resignation of Chief Accounting Officer - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

IO Biotech announces resignation of chief accounting officer and new appointment By Investing.com - Investing.com South Africa

Nov 21, 2025
pulisher
Nov 21, 2025

IO Biotech Announces Management Changes - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

[8-K] IO Biotech, Inc. Reports Material Event | IOBT SEC FilingForm 8-K - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

IO Biotech, Inc. Announces Executive Changes - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

Can IO Biotech Inc. stock withstand economic slowdown2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - The Spec

Nov 20, 2025
pulisher
Nov 19, 2025

Piper Sandler reiterates Overweight rating on IO Biotech stock By Investing.com - Investing.com South Africa

Nov 19, 2025
pulisher
Nov 19, 2025

Is IO Biotech Inc. stock entering bullish territoryJuly 2025 Review & Fast Gaining Stock Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is IO Biotech Inc. stock a top momentum playWeekly Stock Analysis & Daily Price Action Insights - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why - Yahoo Finance

Nov 19, 2025
pulisher
Nov 19, 2025

Will IO Biotech Inc. stock deliver long term returns2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Piper Sandler reiterates Overweight rating on IO Biotech stock - Investing.com India

Nov 19, 2025
pulisher
Nov 19, 2025

IO Biotech Inc. (IOBT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 19, 2025
pulisher
Nov 19, 2025

Is IO Biotech Inc. stock safe for conservative investorsPortfolio Return Summary & Reliable Volume Spike Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

IO Biotech’s Q3 2025: Progress in Cancer Vaccine Trials - MSN

Nov 19, 2025
pulisher
Nov 18, 2025

IO Biotech Presents at Jefferies Global Healthcare Conference - MSN

Nov 18, 2025
pulisher
Nov 18, 2025

IO Biotech Inc (IOBT) is looking forward to a strong quarter - Setenews

Nov 18, 2025
pulisher
Nov 18, 2025

IO Biotech, Inc. Updates on Cylembio Phase 3 Trial Results - TradingView

Nov 18, 2025
pulisher
Nov 18, 2025

Will IO Biotech Inc. see short term momentum2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Sector ETF performance correlation with IO Biotech Inc.Market Trend Review & Smart Allocation Stock Reports - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Is IO Biotech Inc. meeting your algorithmic filter criteriaEarnings Miss & High Conviction Investment Ideas - newser.com

Nov 17, 2025
pulisher
Nov 15, 2025

What moving averages say about IO Biotech Inc.Stock Surge & Low Risk High Reward Trade Ideas - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

IO Biotech’s Hold Rating Amid Financial and Regulatory Uncertainty - TipRanks

Nov 15, 2025
pulisher
Nov 15, 2025

Will IO Biotech Inc. stock outperform tech sector in 2025Bull Run & Weekly High Momentum Picks - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

IO Biotech, Inc.Common Stock (Nasdaq:IOBT) Detailed Stock Data | PRN_FinancialWrapper | PR Newswire - Markets Financial Content

Nov 14, 2025
pulisher
Nov 14, 2025

Will IO Biotech Inc. stock benefit from green energy trendsWeekly Volume Report & Free Risk Controlled Daily Trade Plans - Fundação Cultural do Pará

Nov 14, 2025
pulisher
Nov 14, 2025

IO Biotech, Inc. SEC 10-Q Report - TradingView

Nov 14, 2025
pulisher
Nov 14, 2025

IO Biotech reports $8.4 mln Q3 net loss - MarketScreener

Nov 14, 2025
pulisher
Nov 14, 2025

IO Biotech Reports Phase 3 Clinical Trial Data for Cylembio in Advanced Melanoma and Third Quarter 2025 Financial Results - Quiver Quantitative

Nov 14, 2025
pulisher
Nov 14, 2025

IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights - The Manila Times

Nov 14, 2025
$39.73
price up icon 1.44%
$31.74
price down icon 0.91%
$102.52
price up icon 2.03%
$96.25
price up icon 0.27%
biotechnology ONC
$322.63
price down icon 2.61%
$204.00
price down icon 0.51%
Kapitalisierung:     |  Volumen (24h):